Manufacturing news briefs – stories you might have missed

Clinical trials begin for Australian developed Covid-19 vaccines Clinical human trials have begun on subjects in Melbourne to test the effectiveness and safety of two Melbourne-developed Covid-19 vaccines. The traditional protein-based vaccine was developed by the Doherty Institute, while a mRNA vaccine was developed by Monash Institute of Pharmaceutical Sciences. Melbourne’s IDT Australia manufactured the…

Manufacturing news briefs – stories you might have missed

IDT misses out on MMI grant for mRNA vaccines Drug manufacturer IDT Australia has missed out on a Modern Manufacturing Initiative collaboration stream grant from the federal government to further development of mRNA vaccine manufacturing capabilities. The company, which is manufacturing the vaccine components for clinical trials of a mRNA vaccine developed by Monash University,…

1.5 years after starting a process, Canberra backs commercial mRNA vaccine manufacture

By Peter Roberts Prime Minister Scott Morrison announced today that state and federal governments and vaccine producer Moderna had signed an ‘in principle’ deal for the construction of a Melbourne plant capable of utilising the newly successful vaccine production technologies that produced the Pfizer and Moderna vaccines. The plant would be capable of producing up…

Covid brings Victorian vaccine and pharmaceutical innovation

By Peter Roberts The pieces are beginning to fall into place for the production of mRNA vaccines in Victoria, and possibly Queensland. Driven by the success of the first vaccine’s developed using the novel technology by Pfizer and Moderna, both states are backing local mRNA technology development, with Victoria in April committing $50 million. A…